BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10695716)

  • 1. Use of peptide ligands to analyze the fine specificity of antibodies against asialo GM1.
    Qiu JX; Marcus DM
    J Neuroimmunol; 1999 Dec; 100(1-2):58-63. PubMed ID: 10695716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function studies of an anti-asialo GM1 antibody obtained from a phage display library.
    Qiu JX; Kai M; Padlan EA; Marcus DM
    J Neuroimmunol; 1999 Jun; 97(1-2):172-81. PubMed ID: 10408972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and structure of murine monoclonal antibodies against GM1 ganglioside.
    Weng NP; Ritter E; Yucel E; Zhang D; Ritter G; Marcus DM
    J Neuroimmunol; 1994 Nov; 55(1):61-8. PubMed ID: 7525643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and specificity of 11 monoclonal antibodies to GM1 ganglioside.
    Mahadik SP; Laev H; Rapport MM
    J Neurochem; 1986 Oct; 47(4):1172-5. PubMed ID: 2427655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
    Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
    J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of monoclonal antibodies against a glycolipid asialo GM1.
    Shimada S; Iwata D
    Microbiol Immunol; 1987; 31(9):923-33. PubMed ID: 3696009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
    J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
    Xu Y; Ramsland PA; Davies JM; Scealy M; Nandakumar KS; Holmdahl R; Rowley MJ
    Mol Immunol; 2004 Jun; 41(4):411-9. PubMed ID: 15163538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells.
    Solomon FR; Higgins TJ
    Mol Immunol; 1987 Jan; 24(1):57-65. PubMed ID: 3614206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.
    Jauberteau MO; Gualde N; Preud'Homme JL; Rigaud M; Gil R; Vallat JM; Baumann N
    Clin Exp Immunol; 1990 May; 80(2):186-91. PubMed ID: 2357844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetics approach to the characterization of an IgM specific for the glycolipid asialo-GM1.
    Harrison BA; MacKenzie R; Hirama T; Lee KK; Altman E
    J Immunol Methods; 1998 Mar; 212(1):29-39. PubMed ID: 9671150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies.
    Weng NP; Yu-Lee LY; Sanz I; Patten BM; Marcus DM
    J Immunol; 1992 Oct; 149(7):2518-29. PubMed ID: 1527391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides.
    Wirguin I; Suturkova-Milosevic L; Della-Latta P; Fisher T; Brown RH; Latov N
    Ann Neurol; 1994 Jun; 35(6):698-703. PubMed ID: 8210226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
    Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
    Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolipids noncovalently bound to DEAE-Sephadex. Use of the complexes for purification of IgM and IgG anti-(Gal beta 1-->3 GalNAc-) antibodies.
    Rodriguez PE; Barra JL; Cumar FA
    Biochem Mol Biol Int; 1994 May; 33(2):273-81. PubMed ID: 7524899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies.
    O'Hanlon GM; Paterson GJ; Veitch J; Wilson G; Willison HJ
    Acta Neuropathol; 1998 Jun; 95(6):605-16. PubMed ID: 9650753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
    Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
    J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of kappa light chain contribution to anti-DNA antibody activity of a human VH4-21-encoded monoclonal antibody (NE-1) by antibody-phage display technique.
    Katsube Y; Suzuki H; Muryoi T; Sasaki T
    Int J Mol Med; 1998 May; 1(5):863-8. PubMed ID: 9852308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues.
    Watarai S; Kiura K; Shigeto R; Shibayama T; Kimura I; Yasuda T
    J Biochem; 1994 Nov; 116(5):948-54. PubMed ID: 7896755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.